MedPath

Growing up with the Young Endocrine Support System (YESS!): innovative e-technology to improve transition from paediatric to adult care

Conditions
Congenital adrenal hyperplasia, hypogonadotropic hypogonadism, growth hormone deficiency, combined pituitary hormone deficiency, Turner Syndrome or Klinefelter syndrome.
Registration Number
NL-OMON24682
Lead Sponsor
Erasmus Medical Center
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
160
Inclusion Criteria

Aged 15 to 20 years old.
- Diagnosed with congenital adrenal hyperplasia, hypogonadotropic hypogonadism, growth hormone deficiency, combined pituitary hormone deficiency, Turner Syndrome or Klinefelter syndrome.

Exclusion Criteria

-Lack of a mobile phone or tablet.
-Mental disability or language barrier leading to inability to use the YESS! game or the control game.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To investigate whether there is a difference in the Self-management and Transition to Adulthood with Rx (treatment) (STARx) questionnaire score in group YT compared to group O after 12 months
Secondary Outcome Measures
NameTimeMethod
-To investigate whether there is a difference in the Self-management and Transition to Adulthood with Rx (treatment) (STARx) questionnaire score in group YT compared to group GT and -T after 12 months. <br>-To investigate whether there is a difference in the Self-management and Transition to Adulthood with Rx (treatment) (STARx) questionnaire score in group YT compared to group GT, -T and -O after 6 months.<br>-To investigate whether there is a difference in the drop-out rate to the adult outpatient clinic in group YT compared to group GT, -T and -O during the first year after the last visit to the paediatric endocrinologist (i.e. one year after the moment of transfer, t=24 m). <br>
© Copyright 2025. All Rights Reserved by MedPath